His groundbreaking work on T cells and immune regulation has paved the way for innovative immunotherapies, offering new hope to millions of patients living with autoimmune and inflammatory diseases. Dr. Ramsdell’s visionary science continues to inspire us all at selectION as we work toward advancing immune-based treatments that change lives.
Site Search
Recent News
- selectION Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease
- Congratulations to our Scientific Advisor, Dr. Fred Ramsdell, for receiving the 2025 Nobel Prize in Physiology.
- Meet selectION, Inc. at BIO International Convention in Boston,MA, on June 16th-19th, 2025
